Therapy Areas
23 February 2024 - Pharmaceutical company Janssen, a subsidiary of Johnson & Johnson (NYSE:JNJ), announced on Friday that it has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
23 February 2024 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US-based biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) announced on Friday that the US Food and Drug Administration (FDA) has accepted ...
23 February 2024 - Delcath Systems, Inc. (Nasdaq: DCTH), a New York-based interventional oncology company, announced on Thursday that it has introduced a Healthcare Setting Locator (Locator) on the hepzatokit.com website.Potential patients, caregiver...
23 February 2024 - TC BioPharm (Holdings) PLC (TCBP) (NASDAQ: TCBP) a UK-based clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, announced on Thursday that the UK regula...
23 February 2024 - Elevation Oncology, Inc. (Nasdaq: ELEV), a US-based innovative oncology company, announced on Thursday that it has expanded its ongoing Phase one clinical trial of EO-3021 outside the United States and dosed the first patient in Ja...
23 February 2024 - Astellas Pharma Inc, a United States affiliate of Japan-based Astellas Pharma Inc., announced on Thursday that it has appointed Michael Petroutsas as its new head, United States Commercial.Petroutsas is to head Astellas Pharma'...
21 February 2024 - Clinical-stage immunotherapy firm ImmunityBio (NASDAQ: IBRX), completes accrual of the first two phases of a national trial assessing its Nant Cancer Vaccine (NCV) in participants with Lynch syndrome.Utilising a tri-valent Adenovir...